Quantcast

Latest Bionovo Stories

2008-11-04 09:00:30

Bionovo, a clinical stage drug discovery and development company, has announced that its drug candidate for metastatic breast cancer, BZL101, will advance to Phase II clinical testing after the successful completion of a second Phase I clinical trial. The Phase Ib clinical trial was conducted to identify the maximum tolerated dose of BZL101 and to determine the safety and feasibility of the company's novel, oral, anticancer treatment. A total of 27 women with metastatic breast cancer were...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'